DPP4 and COVID-19: It was also hypothesized that dipeptidyl peptidase 4 (DPP4) could be a functional receptor for the S protein of SARS-CoV-2 [48]; if so, the DPP4 inhibitors may play a role in preventing and decreasing the risk and progression of COVID-19 [49].